Click on image to open expanded view
Item No.
32483
Prascend Tablets for Horses Rx
AutoShip & Save 20%
Count:
You may also like
Product Description
Pituitary Pars Intermedia Dysfunction (PPID), formerly known as equine Cushing’s disease can often go undiagnosed. Previously thought of as an older horse disease, more and more horses are being diagnosed at an earlier age, some as young as 5 years of age.
What is Prascend Tablets for Horses?
Prascend tablets is meant for horses to effectively reduce the signs and symptoms of cushings disease (Pituitary Pars Intermedia Dysfunction).
Who is Prascend Tablets for Horses for?
Horses
Why use Prascend Tablets for Horses?
Reduces signs like fat in unusual places or an abnormal hair coat.
The first and only medicine available in the US to treat PPID (equine Cushing's disease)
Fully approved by the FDA
How does Prascend Tablets for Horses work?
Prascend tablets work as a dopamine receptor agonist used orally in horses.
Manufacturer:
Boehringer Ingelheim
Active Ingredients(s):
pergolide mesylate
How is Prascend Tablets for Horses sold?
60 Tablets
120 Tablets
What are the side effects of Prascend Tablets for Horses?
In some cases decreased appetite, lameness, diarrhea/loose stool, colic, lethargy, abnormal weight loss, laminitis, heart murmur, tooth disorder, skin abscess, musculoskeletal pain & behavior change.
What special precautions are there?
Prascend tablets should not be crushed due to the risk of human exposure. Instead, dissolve Prascend tablets in water and syringed into the horse's mouth or top dressed on his feed, or the undissolved tablet may be placed into an apple or other treat and given to the horse.
What to do if overdose?
Contact your nearest emergency animal hospital.
How can I store Prascend Tablets for Horses?
Store at or below 25°C (77°F)
Helpful Tips:
Talk to your veterinarian to see if PRASCEND is right for your horse.
Overview
Administer orally at a starting dose of 2.0 µg/kg once daily. Dosage may be adjusted to effect, not to exceed 4.0 µg/kg daily. Prascend Tablets should not be crushed due to the potential for increased human exposure.
The tablets are scored and the calculated dosage should be provided to the nearest one-half tablet increment.
| |||||||||||||||
|
Dosing should be titrated according to individual response to therapy to achieve the lowest effective dose. Dose titration is based on improvement in clinical signs associated with Pituitary Pars Intermedia Dysfunction (PPID) and/or improvement or normalization of endocrine tests (for example, dexamethasone suppression test or endogenous ACTH test). If signs of dose intolerance develop, the dose should be decreased by half for 3 to 5 days and then titrated back up in 2 mcg/kg increments every 2 weeks until the desired effect is achieved.
Main Ingredients
Prascend Tablets are rectangular light red colored, half-scored tablets containing 1 mg pergolide, as pergolide mesylate.
Pergolide mesylate is a synthetic ergot derivative and is a potent dopamine receptor agonist. The chemical name of pergolide mesylate is 8β-[(Methylthio) methyl]-6-propylergoline monomethanesulfonate.